ID   NZM080
AC   CVCL_0D43
SY   NZM80
DR   BioSample; SAMN14558350
DR   Wikidata; Q54931622
RX   PubMed=32567790;
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 14,18
ST   D19S433: 14,15.2
ST   D2S1338: 22
ST   D3S1358: 18,19
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 19,23
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
RX   PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249;
RA   Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J.,
RA   Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S.,
RA   Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.;
RT   "Genomic and signalling pathway characterization of the NZM panel of
RT   melanoma cell lines: a valuable model for studying the impact of
RT   genetic diversity in melanoma.";
RL   Pigment Cell Melanoma Res. 34:136-143(2021).
//